Company Filing History:
2 out of 528 
2 out of 448 
2 out of 126 
Years Active: 2010-2015
Title: The Innovative Contributions of Sandra Carrouee
Introduction
Sandra Carrouee is a notable inventor based in Lyons, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target viral infections. With a total of 2 patents to her name, her work is paving the way for new treatment options.
Latest Patents
Carrouee's latest patents focus on long chain N-alkyl compounds and their oxa-derivatives. These compounds include long chain N-alkyl amino and imino compounds, as well as oxa-substituted derivatives. The long chain N-alkyl group is characterized as a C-Calkyl group. These innovative compounds are particularly promising for the treatment of viral infections, specifically targeting the hepatitis B virus and hepatitis C virus. The long chain N-alkyl compounds can be derived from various chemical structures, including piperidines, pyrrolidines, phenylamines, pyridines, pyrroles, and amino acids.
Career Highlights
Throughout her career, Sandra Carrouee has worked with esteemed institutions such as Thomas Jefferson University and Oxford University Innovation Limited. Her research has contributed to advancements in the pharmaceutical field, particularly in the development of new therapeutic agents.
Collaborations
Carrouee has collaborated with notable colleagues, including Nicole Zitzmann and Terry D Butters. These partnerships have further enhanced her research and innovation in the field.
Conclusion
Sandra Carrouee's contributions to the field of pharmaceutical chemistry are noteworthy. Her innovative patents and collaborations highlight her commitment to advancing treatment options for viral infections. Her work continues to inspire future research and development in this critical area of medicine.